Drawing for E*CTR

USPTO serial 77506578

E*CTR

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
GOODMAN, WENDY BETH
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with E*CTR?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kenneth I. Kohn

KENNETH I. KOHN KOHN & ASSOCIATES, PLLC30500 NORTHWESTERN HWY STE 410FARMINGTON HILLS, MI 48334-3179UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035Data processing services; Providing statistical information for business or commercial purposes; Business auditing services; data processing services in the biostatistics field; Performing statistical analysis for business purposes; Manufacturer representatives in the field of pharmaceuticals; development of business processes for the analysis and implementation of clinical trials dealing with pharmaceutical drug developmentACTIVE—
042Providing online computer database for use in gathering and providing clinical trial data regarding medical and scientific research; Scientific research; Product research and development; medical and scientific research services in the field of treatment and diagnosis provided for medical service providers; Technical writing for others; Providing quality assurance services in the field of pharmaceuticals; medical and scientific research featuring troubleshooting product and process development problems dealing with safety and regulatory toxicology programs in the field of pharmaceutical drugs; Medical and scientific research, namely, conducting clinical trials; Consultation in the fields of pharmaceutical drug development and conducting clinical trials; consultation in the fields of pharmaceutical drug development, namely, consulting with sponsor, medical, scientific, toxicology, manufacturing and business experts to clearly delineate development requirements and evaluate available and competitive technologies; Product development; Technical writing for others, namely, writing integrated clinical and statistical study reports and other regulatory manuscripts; compiling data in the nature of patient records via a global computer information network for research purposes in the field of medical science and medical consultancyACTIVE—
045Reviewing standards and practices to assure compliance with medical and pharmaceutical laws and regulations; reviewing standards and practices to assure compliance with US Food and Drug Administration (FDA) laws and regulations; legal consulting services regarding Food and Drug law and regulation compliance, namely, consulting in the preparation of legal negotiations, in the preparation of legal documents and forms required by the FDA, in the preparation of responses to FDA questions and warning letters, and the follow-up with FDA on post application submission questions, in the preparation of meetings with legal counsel; intellectual property licensing in the fields of drug, drug product, pharmaceutical and pharmaceutical productsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Apr 12, 2010MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Apr 12, 2010ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 8, 2009NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 16, 2009PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 27, 2009NPUBNOTICE OF PUBLICATION—
May 12, 2009PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
May 11, 2009CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 11, 2009XAECEXAMINER'S AMENDMENT ENTERED—
May 11, 2009GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
May 11, 2009GNEAEXAMINERS AMENDMENT E-MAILED—
May 11, 2009CNEAEXAMINERS AMENDMENT -WRITTEN—
Apr 24, 2009ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Mar 23, 2009PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Mar 9, 2009PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Mar 9, 2009ALIEASSIGNED TO LIE—
Mar 7, 2009CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 7, 2009XAECEXAMINER'S AMENDMENT ENTERED—
Mar 7, 2009GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 7, 2009GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 7, 2009CNEAEXAMINERS AMENDMENT -WRITTEN—
Oct 16, 2008GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 16, 2008GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 16, 2008CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 28, 2008DOCKASSIGNED TO EXAMINER—
Jun 27, 2008NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance